SAR-445399

N/A

Report date: 2026/05/28 20:00:21

Base Information

Drug NameSAR-445399
Drug Alias NameSAR-445399
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionAnti-Interleukin-1 receptor accessory protein
TargetsInterleukin-1 receptor accessory protein
Therapy Area/IndicationsInflammationImmune System DiseasesBronchiectasis +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumCanadaUnited States +[15] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesSanofi
China Registration ClassN/A

Develop Information

Active CompaniesSanofiSanofi-Aventis Recherche & DeveloppementSanofi (China) Investment Co Ltd
Inactive CompaniesN/A
Active IndicationsInflammationImmune System DiseasesBronchiectasis +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A